Tweet
Hello, I am Kombo Gayus Habila, Lab Manager, Oncogenomics Laboratory, Lagos Nigeria. i am very glad to be here
-
-
Welcome GKombong! We're happy to have you join the community. Let us know if there is anything you need help with. -
Hi every one!. At Oncogenomics Lab we've being enjoying using Miseq FGX for sequencing and it was giving excellent results. But recently we received a new supply from our in-country suppliers. we used the reagents and had three consecutive test runs stopping after read 1. There was no error alarm or error code to that effect on the machine. In all the stopped runs, the quality metrics were excellent but till now we are yet to figure out whats wrong. Please has any body experience a similar problem? Meanwhile, the last run from the old stock of reagent didn't have any issue, the machine's available memory is 81% and no any alert for software update.Comment
-
Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...07-11-2026, 01:13 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment